Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Clin Exp Dent Res ; 7(5): 664-671, 2021 10.
Article in English | MEDLINE | ID: mdl-33942562

ABSTRACT

OBJECTIVES: The aim of this systematic review is to summarize the available data on the effects of organic unprocessed products in treating gingivitis during treatment with fixed orthodontic appliances. MATERIALS AND METHODS: Multiple electronic databases were searched up to October 1, 2020. Randomized controlled trials (RCTs), controlled clinical trials, cohort studies of prospective and retrospective design, and cross-sectional studies reporting on natural products for controlling gingivitis in orthodontic patients were eligible for inclusion. The quality of the included RCTs was assessed per the revised Cochrane risk of bias tool for randomized trials (RoB 2.0). RESULTS: Three RCTs were finally eligible for inclusion, yielding a total of 135 patients with an age range of 12-40 years. Organic products used were Aloe vera mouth rinse, ingestion of honey and chamomile mouthwash. Treatment follow-up period varied from 30 min to 15 days. The results indicated that the use of the aforementioned organic products significantly reduced plaque and gingival bleeding levels as early as treatment started. The reduction in biofilm accumulation and gingival bleeding was significant throughout the studies' follow-up. CONCLUSIONS: Owing to their antimicrobial and anti-inflammatory properties, nonpharmacological formulations successfully controlled gingival inflammation and plaque indices in orthodontic patients.


Subject(s)
Dental Plaque , Gingivitis , Adolescent , Adult , Child , Dental Plaque/prevention & control , Dental Plaque Index , Gingivitis/drug therapy , Gingivitis/prevention & control , Humans , Mouthwashes/therapeutic use , Orthodontic Appliances, Fixed/adverse effects , Randomized Controlled Trials as Topic , Young Adult
2.
J Pediatr ; 220: 21-26.e1, 2020 05.
Article in English | MEDLINE | ID: mdl-32093926

ABSTRACT

OBJECTIVE: To explore the effect of early-onset preeclampsia on the blood pressure of offspring during the first month of life. STUDY DESIGN: This prospective case-control study included 106 neonates of mothers with early-onset preeclampsia (developing at <34 weeks of gestation) and 106 infants of normotensive mothers, matched 1-to-1 for sex and gestational age. Serial blood pressure measurements were obtained on admission, daily for the first postnatal week, and then weekly up to the fourth week of life. RESULTS: There were no differences in blood pressure values on admission and the first day of life between cases and controls. Conversely, infants exposed to preeclampsia had significantly higher systolic (SBP), diastolic (DBP), and mean blood pressure (MBP) on the subsequent days up to the fourth postnatal week (P <.001-.033). Multiple regression analyses with adjustment for sex, gestational age, antenatal corticosteroid use, and maternal antihypertensive medication use confirmed the foregoing findings (P <.001-.048). Repeated-measures ANOVA also identified preeclampsia as a significant determinant of trends in SBP, DBP, and MBP during the first month of life (F = 16.2, P < .001; F = 16.4, P < .001; and F = 17.7, P < .001, respectively). CONCLUSIONS: Infants of mothers with early-onset preeclampsia have elevated blood pressure values throughout the neonatal period compared with infants born to normotensive mothers.


Subject(s)
Diastole/physiology , Hypertension/physiopathology , Pre-Eclampsia/physiopathology , Systole/physiology , Adult , Case-Control Studies , Female , Gestational Age , Humans , Infant, Newborn , Male , Pregnancy , Prospective Studies
3.
Early Hum Dev ; 135: 1-5, 2019 08.
Article in English | MEDLINE | ID: mdl-31176082

ABSTRACT

BACKGROUND: Pre-eclampsia is a known risk factor for long-term cardiovascular complications. Osteoprotegerin (OPG) and the receptor activator of nuclear factor κB ligand (RANKL) have been implicated in the pathogenesis of cardiovascular disease. The OPG-RANKL axis function is also altered in pregnant women with pre-eclampsia, but there is lack of data regarding OPG and RANKL concentrations in their neonates. AIMS: To examine the effects of early-onset pre-eclampsia on OPG and RANKL serum concentrations at birth, taking into account the influence of various perinatal factors. STUDY DESIGN: OPG and RANKL serum concentrations were measured in 28 premature newborns of mothers with early onset pre-eclampsia, and in 28 preterm and 28 full-term neonates of normotensive mothers (control groups). RESULTS: Neonates of pre-eclamptic mothers had higher OPG and lower RANKL levels compared to both control groups (Kruskal-Wallis P < 0.0001 and P = 0.014, respectively). Regression analysis showed that pre-eclampsia (P < 0.0001), birth weight z-score (P = 0.048) and antenatal steroid administration (P = 0.034) were significant determinants of OPG levels. Multivariable regression analysis also showed that pre-eclampsia was an independent predictor of increased diastolic and mean blood pressure in these neonates. CONCLUSIONS: Early-onset pre-eclampsia affects OPG concentrations at birth and is an independent predictor of increased blood pressure in the offspring. Our findings suggest that altered OPG-RANKL axis function may be one of the mechanisms of cardiovascular 'programming' in fetuses exposed to pre-eclampsia.


Subject(s)
Hypertension/blood , Infant, Newborn/blood , Osteoprotegerin/blood , Pre-Eclampsia/epidemiology , Prenatal Exposure Delayed Effects/blood , RANK Ligand/blood , Adult , Biomarkers/blood , Blood Pressure , Female , Humans , Hypertension/epidemiology , Male , Pregnancy , Prenatal Exposure Delayed Effects/epidemiology
5.
Mol Cell Probes ; 22(1): 24-9, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17669623

ABSTRACT

Blastocystis is an anaerobic parasitic microorganism, which has been found in the intestinal tract of many vertebrates including humans. Recently, members of Blastocystis sp. were classified into nine subtypes, based on phylogenetic trees derived from sequence analysis of the small subunit ribosomal RNA (SSU rRNA) gene. The role of Blastocystis in human disease remains uncertain and the existence of pathogenic and non-pathogenic subtypes is under investigation. We report the development of a polymerase chain reaction (PCR)-based assay that is able to detect Blastocystis directly from human faeces. Furthermore, combined with single strand conformational polymorphism (SSCP) analysis and/or sequencing of the respective PCR product, the protocol can classify Blastocystis among the nine established subtypes. The method was applied to 45-positive and 30-negative faecal samples and proved to be highly sensitive and specific. Genotyping using SSCP analysis and sequencing revealed that subtype 3 is the most frequent in Greece, while subtypes 1, 2, 4, 6 and 7 are also present but in lower frequencies. Hopefully, the simplicity of the proposed method will contribute toward large-scale epidemiological studies for prompt clarification of the role of the parasite.


Subject(s)
Blastocystis/classification , Blastocystis/isolation & purification , DNA, Protozoan/analysis , DNA, Protozoan/genetics , Feces/parasitology , Polymorphism, Single-Stranded Conformational/genetics , Animals , Blastocystis/genetics , Humans , Phylogeny , Polymerase Chain Reaction , Sensitivity and Specificity , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...